Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 48.16
-4.44 (-8.44%)
Jul 30, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 49.57 billion as of July 30, 2026. Its market cap has increased by 478.56% in one year.
Market Cap
49.57B
Enterprise Value
49.30B
Revenue
1.78B
Ranking
n/a
PE Ratio
64.60
Stock Price
48.16
ChartMarket Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 49.57B, an increase of 380.57%. That is a compound annual growth rate of 49.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 49.57B | 110.16% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 155.55B |
| Sichuan Kelun-Biotech Biopharmaceutical | 122.74B |
| Akeso | 90.82B |
| Sino Biopharmaceutical | 90.63B |
| RemeGen | 68.37B |
| 3SBio | 42.69B |
| Shanghai Junshi Biosciences | 38.01B |
| Genscript Biotech | 36.81B |